Citations

Mayo Clinic

Clear

1132 citation(s) found for "Yu, Yan".

ZUMA-8: A Phase 1 Study of KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Hill, Brian T. , Maris, Michael, Byrne, Michael , Pagel, John M. , Zheng, Yan , Kanska, Justyna, Zhang, Wangshu , Masouleh, Behzad Kharabi, Granados, Enrique , Ibarz, Javier Pinilla, Davids, Matthew S. , Kenderian, Saad S. , Flinn, Ian W. , Ghia, Paolo , Bartlett, Nancy L.

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7454-7456

10.1182/blood-2022-167868 Get It

The Combination of Navitoclax and Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Mediates Responses Suggestive of Disease Modification
Foran, James M. , Tandra, Anand, Mattour, Ahmad, Perkins, Andrew C. , Rodríguez‐Macías, Gabriela , Sibai, Hassan , Sun, Yan , Potluri, Jalaja , Harb, Jason G., How, Jonathan, Perkins, Andrew C , Passamonti, Francesco , Stefano, Valerio De , Fox, María Laura , McMullin, Mary Frances , Qin, Qin

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 583-585

10.1182/blood-2022-157949 Get It

Variation in the Immune Tumor Microenvironment in Relation to Self-Reported Race in Individuals with Multiple Myeloma
Sharma, Neeraj , Tang, Hongwei , Yan, Huihuang , Tian, Shulan , Shivaram, Suganti, Kourelis, Taxiarchis , Kumar, Shaji , Sharma, Neeraj , Tang, Hongwei, Baughn, Linda B.

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4209-4210

10.1182/blood-2022-166744 Get It

CDK7 Inhibition Targets Proliferative and Metabolic Oncogenic Vulnerabilities in Multiple Myeloma
Ng, Jessica Fong, Park, Woojun D. , Morelli, Eugenio , Kwiatkowski, Nicholas , Chyra, Zuzana , Chesi, Marta, Gray, Nathaniel, Young, Richard A., Lin, Charles Y., Munshi, Nikhil C. , Fulciniti, Mariateresa , Morelli, Eugenio , Chyra, Zuzana , Yao, Yao , Samur, Mehmet , Encinas, Jessica , Xu, Yan , Nabet, Behnam , Chesi, Marta , Anderson, Kenneth C.

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9955-9956

10.1182/blood-2022-163811 Get It

Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of ZUMA-1 Cohort 6
Oluwole, Olalekan O. , Forcade, Édouard , Muñoz, Javier, Guibert, Sophie de , Lin, Yi , Deol, Abhinav , McSweeney, Peter A., Kersten, Marie José , Jacobson, Caron A. , Thiéblemont, Catherine , Timmerman, John M. , Stiff, Patrick J. , Tzachanis, Dimitrios , Zheng, Yan , Vardhanabhuti, Saran , Shen, Rhine R. , Miao, Harry , Kim, Jenny , Oluwole, Olalekan O , Vose, Julie M. , Bartlett, Nancy L. , Goy, Andre Henri , Farooq, Umar , Minnema, Monique C , Avivi, Irit , Nater, Jenny , Meerten, Tom van

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10399-10401

10.1182/blood-2022-156117 Get It

A Simple Risk-Scoring Model for Estimating the Prognostic Impact of 1q Gain in Patients with Newly-Diagnosed Multiple Myeloma
Jin, Fengyan, Yang, Pei‐Yu , Chen, Haimin , Liang, Xinyue , Xu, Weiling , Yu, Shanshan , Yi, Xingchen, Tian, Mengru, Yue, Tingting , Yan, Yurong, Hu, Zhongli, Kumar, Shaji , Zhou, Fan , Jin, Fengyan , Huang, Wenyang , Guo, Qiang , Yue, Tingting, Li, Mengyao , Zhang, Yingjie , Zhang, Mengxue , Dai, Yun

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4360-4361

10.1182/blood-2022-168602 Get It

A Single Next Generation Sequencing Assay for Detection of Driver Mutations, Translocations and Copy Number Alterations in Patients with Multiple Myeloma
Campos, Cecília Bonolo de , Smadbeck, James B. , Arribas, Mariano , Ahmann, Gregory , Kumar, Shaji , Stewart, A. Keith, Asmann, Yan W. , Sharma, Neeraj , Stewart, A. Keith, Fonseca, Rafaël , Bergsagel, P. Leif , Baughn, Linda B. , Braggio, Esteban

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7180-7181

10.1182/blood-2022-170749 Get It